Preview

Сибирский научный медицинский журнал

Advanced search

Method of hyaluronidase immobilization to produce an oral dosage form

https://doi.org/10.18699/SSMJ20240209

Abstract

Hyaluronidase is an enzyme that helps maintain an optimal balance of hyaluronic acid in connective tissue and ensures full tissue regeneration. Currently, hyaluronidase drugs are used in various fields of medicine. Meanwhile, there are no oral preparations based on hyaluronidase on the pharmaceutical market due to its low bioavailability in this method of administration. One of the options to increase enzyme bioavailability is electron-beam pegylation, which involves obtaining drugs with a modified pharmacokinetic profile in the direction of increasing enteral bioavailability, as well as having additional protection from the action of proteolytic enzymes. Aim of the study was using the electron beam pegylation method to obtain a laboratory batch of a preparation based on highly purified hyaluronidase, which can be further used in the development of an oral drug product. Material and methods. Hyaluronidase, which was isolated from bovine testicular hyaluronidase and polyethylene glycols of different molecular weight, was used in the experimental study. Experiments were carried out using a pulsed linear accelerator ILU-10 for enzyme electron beam immobilization on a water-soluble polymer matrix of polyethylene glycol molecules. The formation of hyaluronidase and polyethylene glycols conjugates was confirmed by exclusion chromatography. Results. As a result of accelerated electron irradiation of hyaluronidase and polyethylene glycol of molecular mass 1500 Da conjugates of enzyme and polymer matrix were formed. After electron-beam pegylation, the specific activity of the enzyme was retained. Conclusions. A laboratory batch of prototype pharmaceutical substance based on immobilised hyaluronidase on polyethylene glycol was obtained.

About the Authors

А. М. Shvetsova
Research Institute of Clinical and Experimental Lymphology – Branch of the Federal Research Center Institute of Cytology and Genetics of SB RAS
Russian Federation

Alexandra M. Shvetsova

630060, Novosibirsk, Timakova st., 2



К. I. Ershov
Research Institute of Clinical and Experimental Lymphology – Branch of the Federal Research Center Institute of Cytology and Genetics of SB RAS; Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation

Konstantin I. Ershov, candidate of biological sciences

630060, Novosibirsk, Timakova st., 2;

630091, Novosibirsk, Krasny ave., 52

 



М. А. Korolev
Research Institute of Clinical and Experimental Lymphology – Branch of the Federal Research Center Institute of Cytology and Genetics of SB RAS
Russian Federation

Maksim A. Korolev, doctor of medical sciences

630060, Novosibirsk, Timakova st., 2



Р. G. Madonov
Research Institute of Clinical and Experimental Lymphology – Branch of the Federal Research Center Institute of Cytology and Genetics of SB RAS; Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation

Pavel G. Madonov, doctor of medical sciences

630060, Novosibirsk, Timakova st., 2;

630091, Novosibirsk, Krasny ave., 52 

 



L. V. Trubina
Omsk State Medical University of Minzdrav of Russia
Russian Federation

Larisa V. Trubina, candidate of pharmacological sciences

644099, Omsk, Lenina st., 12



References

1. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology. 2003;13(12):105–115. doi: 10.1093/glycob/cwg112

2. Zabanova V.E., Fursova A.Z., Madonov P.G. Hyaluronidase pharmacological properties and clinical application in ophthalmology. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal. 2020;40(4):11–19. [In Russian]. doi: 10.15372/SSMJ20200402

3. Instructions for medical use of the medicine Longidaza. Registration certificate LS-000764- 220818. Available at: https://www.vidal.ru/drugs/longidaze__31621. [In Russian].

4. Dygai A.M., Zyuzkov G.N., Churin A.A., Zhda-nov V.V., Artamonov A.V., Bekarev A.A., Mado-nov P.G., Kincht D.N., Fomina A.T., Vetoshkina T.V., … Reikhart D.V. Pharmacology of somatrotropin pegylated by electron-beam synthesis nanotechnology. Byulleten’ eksperimental’noy biologii i meditsiny = Bulletin of Experimental Biology and Medicine. 2012;153(2):263–265.

5. Dygai A.M., Zyuzkov G.N., Gurto R.V., Zhdanov V.V., Udut E.V., Miroshnichenko L.A., Simanina E.V., Stavrova L.A., Chaikovsky A.V., Markova T.S., … Bekarev A.A. Effect of pegylated hyaluronate-endoβ-N-acetylhexosaminidase on humoral mechanisms regulating the functions of progenitor cells during chronic hepatitis. Byulleten’ eksperimental’noy biologii i meditsiny = Bulletin of Experimental Biology and Medicine. 2013;155(2):179–182. [In Russian].

6. Dygay A.M., Zyuzkov T.N., Zhdanov V.V., Madonov P.G., Artamonov A.V., Bekarev A.A., Udut V.V. Immobilized granulocyte colony-stimulating factor. Pharmacological properties and prospects of use. Tomsk: Pechatnaya Manufaktura, 2011.149 p. [In Russian].

7. Kinsht D.N., Kochneva G.V., Madonov P.G., Kovaleva N.V. Specific antiviral activity against hepatitis C virus oral drug based on immobilized interferon λ-1. Rational Pharmacotherapy: proc. conf., Saint-Petersburg, October 6–8, 2016. Saint-Petersburg, 2016. 81–83. [In Russian].

8. Bekarev A.A., Artamonov A.V., Vereshchagin E.I. Method of immobilization of biologically active substance (BAS) on a carrier (variants) and BAS-carrier conjugate obtained by these methods. Pat. 2409669 RF; published 20.01.2011. [In Russian].

9. Topchieva I.N. Biochemical applications of poly(ethylene glycol). Uspekhi khimii = Russian Chemical Reviews. 1980;49(3):494–517. [In Russian]. doi: 10.1070/RC1980v049n03ABEH002458

10. Ibragimov A.N., Bikmullin A.G., Sataeva D.A., Lopukhov L.V., Zainullin L.I., Alimova F.K. Chromatographic methods of protein purification. Textbook. Kazan: FGAOU VPO KFU, 2013. 48 p. [In Russian].

11. Shvetsova A.M., Ershov K.I., Korolev M.A., Madonov P.G. Experimental results on the development of highly purified hyaluronate-endo-β-N-acetylhexosaminidase as a pharmaceutical substance for a drug product. Byulleten’ meditsinskoy nauki = Bulletin of Medical Science. 2023;(4):68-80. [In Russian]. doi: 10.31684/25418475-2023-4-68


Review

For citations:


Shvetsova А.М., Ershov К.I., Korolev М.А., Madonov Р.G., Trubina L.V. Method of hyaluronidase immobilization to produce an oral dosage form. Сибирский научный медицинский журнал. 2024;44(2):73-79. (In Russ.) https://doi.org/10.18699/SSMJ20240209

Views: 483


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2410-2512 (Print)
ISSN 2410-2520 (Online)